-
1
-
-
0242441465
-
Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
-
Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003;42:1050-65.
-
(2003)
Hypertension
, vol.42
, pp. 1050-1065
-
-
Sarnak, M.J.1
Levey, A.S.2
Schoolwerth, A.C.3
Coresh, J.4
Culleton, B.5
Hamm, L.L.6
-
2
-
-
33745852282
-
Chronic kidney disease and mortality risk: A systematic review
-
Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006;17:2034-47.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 2034-2047
-
-
Tonelli, M.1
Wiebe, N.2
Culleton, B.3
House, A.4
Rabbat, C.5
Fok, M.6
-
3
-
-
4644221457
-
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
-
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
-
(2004)
N Engl J Med
, vol.351
, pp. 1296-1305
-
-
Go, A.S.1
Chertow, G.M.2
Fan, D.3
McCulloch, C.E.4
Hsu, C.Y.5
-
4
-
-
0037420121
-
Why is chronic kidney disease the "spoiler" for cardiovascular outcomes?
-
McCullough PA. Why is chronic kidney disease the "spoiler" for cardiovascular outcomes? J Am Coll Cardiol 2003;41:725-8.
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 725-728
-
-
McCullough, P.A.1
-
5
-
-
0035134192
-
End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?
-
Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 2001;59:407-14.
-
(2001)
Kidney Int
, vol.59
, pp. 407-414
-
-
Arici, M.1
Walls, J.2
-
6
-
-
0033552883
-
Atherosclerosis--an inflammatory disease
-
Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999;340:115-26.
-
(1999)
N Engl J Med
, vol.340
, pp. 115-126
-
-
Ross, R.1
-
7
-
-
0347716452
-
The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease
-
Muntner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 2004;140: 9-17.
-
(2004)
Ann Intern Med
, vol.140
, pp. 9-17
-
-
Muntner, P.1
Hamm, L.L.2
Kusek, J.W.3
Chen, J.4
Whelton, P.K.5
He, J.6
-
8
-
-
26944473274
-
C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease
-
Menon V, Greene T, Wang X, Pereira AA, Marcovina SM, Beck GJ, et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 2005;68:766-72.
-
(2005)
Kidney Int
, vol.68
, pp. 766-772
-
-
Menon, V.1
Greene, T.2
Wang, X.3
Pereira, A.A.4
Marcovina, S.M.5
Beck, G.J.6
-
9
-
-
33746012877
-
Do inflammatory markers add predictive information of death beyond that provided by age and comorbidity in chronic renal failure patients?
-
Caravaca F, Martín MV, Barroso S, Ruiz B, Hernández-Gallego R. Do inflammatory markers add predictive information of death beyond that provided by age and comorbidity in chronic renal failure patients? Nephrol Dial Transplant 2006;21:1575-81.
-
(2006)
Nephrol Dial Transplant
, vol.21
, pp. 1575-1581
-
-
Caravaca, F.1
Martín, M.V.2
Barroso, S.3
Ruiz, B.4
Hernández-Gallego, R.5
-
10
-
-
79958093858
-
Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community
-
Goel K, Lennon RJ, Tilbury RT, Squires RW, Thomas RJ. Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community. Circulation 2011;123:2344-52.
-
(2011)
Circulation
, vol.123
, pp. 2344-2352
-
-
Goel, K.1
Lennon, R.J.2
Tilbury, R.T.3
Squires, R.W.4
Thomas, R.J.5
-
11
-
-
40849092775
-
Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome
-
Mielniczuk LM, Pfeffer MA, Lewis EF, Blazing MA, de Lemos JA, Shui A, et al. Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome. Am Heart J 2008;155:725-31.
-
(2008)
Am Heart J
, vol.155
, pp. 725-731
-
-
Mielniczuk, L.M.1
Pfeffer, M.A.2
Lewis, E.F.3
Blazing, M.A.4
de Lemos, J.A.5
Shui, A.6
-
12
-
-
73449125865
-
Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome
-
Mielniczuk LM, Pfeffer MA, Lewis EF, Blazing MA, de Lemos JA, Mohanavelu S, et al. Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome. Clin J Am Soc Nephrol 2009;4:1811-7.
-
(2009)
Clin J Am Soc Nephrol
, vol.4
, pp. 1811-1817
-
-
Mielniczuk, L.M.1
Pfeffer, M.A.2
Lewis, E.F.3
Blazing, M.A.4
de Lemos, J.A.5
Mohanavelu, S.6
-
13
-
-
56749106312
-
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
-
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359:2195-207.
-
(2008)
N Engl J Med
, vol.359
, pp. 2195-2207
-
-
Ridker, P.M.1
Danielson, E.2
Fonseca, F.A.3
Genest, J.4
Gotto Jr., A.M.5
Kastelein, J.J.6
-
14
-
-
71649114494
-
Clinical implications of JUPITER (Justification for the Use of statins in Prevention: An Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study
-
Yang EY, Nambi V, Tang Z, Virani SS, Boerwinkle E, Hoogeveen RC, et al. Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol 2009;54: 2388-95.
-
(2009)
J Am Coll Cardiol
, vol.54
, pp. 2388-2395
-
-
Yang, E.Y.1
Nambi, V.2
Tang, Z.3
Virani, S.S.4
Boerwinkle, E.5
Hoogeveen, R.C.6
-
15
-
-
65649142017
-
A new equation to estimate glomerular filtration rate
-
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12.
-
(2009)
Ann Intern Med
, vol.150
, pp. 604-612
-
-
Levey, A.S.1
Stevens, L.A.2
Schmid, C.H.3
Zhang, Y.L.4
Castro III, A.F.5
Feldman, H.I.6
-
16
-
-
0036176161
-
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
-
National Kidney Foundation
-
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1-266.
-
(2002)
Am J Kidney Dis
, vol.39
, Issue.2 SUPPL. 1
-
-
-
17
-
-
20144387681
-
Cardiovascular mortality risk in chronic kidney disease: Comparison of traditional and novel risk factors
-
Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 2005;293:1737-45.
-
(2005)
JAMA
, vol.293
, pp. 1737-1745
-
-
Shlipak, M.G.1
Fried, L.F.2
Cushman, M.3
Manolio, T.A.4
Peterson, D.5
Stehman-Breen, C.6
-
18
-
-
38649103152
-
Amino-terminal pro-B-type natriuretic peptide testing in renal disease
-
DeFilippi C, van Kimmenade RR, Pinto YM. Amino-terminal pro-B-type natriuretic peptide testing in renal disease. Am J Cardiol 2008;101:82-8.
-
(2008)
Am J Cardiol
, vol.101
, pp. 82-88
-
-
DeFilippi, C.1
van Kimmenade, R.R.2
Pinto, Y.M.3
-
19
-
-
0142157737
-
Malnutrition-inflammation complex syndrome in dialysis patients: Causes and consequences
-
Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 2003;42:864-81.
-
(2003)
Am J Kidney Dis
, vol.42
, pp. 864-881
-
-
Kalantar-Zadeh, K.1
Ikizler, T.A.2
Block, G.3
Avram, M.M.4
Kopple, J.D.5
-
20
-
-
84862797441
-
GFR and cardiovascular outcomes after acute myocardial infarction: Results from the Korea Acute Myocardial Infarction Registry
-
Bae EH, Lim SY, Cho KH, Choi JS, Kim CS, Park JW, et al. GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry. Am J Kidney Dis 2012;59:795-802.
-
(2012)
Am J Kidney Dis
, vol.59
, pp. 795-802
-
-
Bae, E.H.1
Lim, S.Y.2
Cho, K.H.3
Choi, J.S.4
Kim, C.S.5
Park, J.W.6
-
21
-
-
0037078969
-
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events
-
Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65.
-
(2002)
N Engl J Med
, vol.347
, pp. 1557-1565
-
-
Ridker, P.M.1
Rifai, N.2
Rose, L.3
Buring, J.E.4
Cook, N.R.5
-
22
-
-
1842587885
-
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
-
Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97.
-
(2004)
N Engl J Med
, vol.350
, pp. 1387-1397
-
-
Danesh, J.1
Wheeler, J.G.2
Hirschfield, G.M.3
Eda, S.4
Eiriksdottir, G.5
Rumley, A.6
-
23
-
-
46849110373
-
Chronic inflammation and mortality in haemodialysis: Effect of different renal replacement therapies. Results from the RISCAVID study
-
Panichi V, Rizza GM, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, et al. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study. Nephrol Dial Transplant 2008;23:2337-43.
-
(2008)
Nephrol Dial Transplant
, vol.23
, pp. 2337-2343
-
-
Panichi, V.1
Rizza, G.M.2
Paoletti, S.3
Bigazzi, R.4
Aloisi, M.5
Barsotti, G.6
-
24
-
-
0034119307
-
The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease
-
Klahr S, Morrissey JJ. The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease. Kidney Int Suppl 2000;75:S7-14.
-
(2000)
Kidney Int Suppl
, vol.75
-
-
Klahr, S.1
Morrissey, J.J.2
-
25
-
-
0037180771
-
Inflammation in atherosclerosis
-
Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74.
-
(2002)
Nature
, vol.420
, pp. 868-874
-
-
Libby, P.1
-
26
-
-
0033597123
-
Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase
-
Rajavashisth TB, Liao JK, Galis ZS, Tripathi S, Laufs U, Tripathi J, et al. Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J Biol Chem 1999;274:11924-9.
-
(1999)
J Biol Chem
, vol.274
, pp. 11924-11929
-
-
Rajavashisth, T.B.1
Liao, J.K.2
Galis, Z.S.3
Tripathi, S.4
Laufs, U.5
Tripathi, J.6
-
27
-
-
77949332406
-
Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: A secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial
-
Ridker PM, MacFadyen J, Cressman M, Glynn RJ. Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial. J Am Coll Cardiol 2010;55:1266-73.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 1266-1273
-
-
Ridker, P.M.1
McFadyen, J.2
Cressman, M.3
Glynn, R.J.4
|